|
Volumn 109, Issue 8, 2007, Pages 3607-
|
Vitamin K supplementation during oral anticoagulation: Cautions [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
FARNOQUINONE;
LOW DENSITY LIPOPROTEIN;
PHYTOMENADIONE;
WARFARIN;
VITAMIN K GROUP;
CARBOXYLASE;
COUMARIN DERIVATIVE;
GLUTAMIC ACID;
MENADIONE EPOXIDE;
MENAQUINONE;
OSTEOCALCIN;
ABSENCE OF SIDE EFFECTS;
ANTICOAGULANT THERAPY;
AORTA VALVE;
ARTERY CALCIFICATION;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG POTENTIATION;
DRUG TRANSPORT;
HUMAN;
INTERNATIONAL NORMALIZED RATIO;
LETTER;
NONHUMAN;
POSTMENOPAUSE;
PRIORITY JOURNAL;
SINGLE DRUG DOSE;
VITAMIN SUPPLEMENTATION;
AGED;
BLOOD;
BLOOD CLOTTING DISORDER;
DIET SUPPLEMENTATION;
DRUG STABILITY;
FEMALE;
MALE;
MIDDLE AGED;
NOTE;
BLEEDING;
DRUG ABSORPTION;
HEART ATRIUM FIBRILLATION;
HEMOSTASIS;
OSSIFICATION;
PROPHYLAXIS;
SOFT TISSUE CALCIFICATION;
THROMBOEMBOLISM;
AGED;
AGED, 80 AND OVER;
ANTICOAGULANTS;
BLOOD COAGULATION DISORDERS;
DIETARY SUPPLEMENTS;
DRUG STABILITY;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
VITAMIN K;
WARFARIN;
|
EID: 34147130338
PISSN: 00064971
EISSN: 00064971
Source Type: Journal
DOI: 10.1182/blood-2006-12-061200 Document Type: Letter |
Times cited : (6)
|
References (10)
|